venlafaxine hydrochloride has been researched along with Pneumonia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al-Jammali, Z; Barrett, T; DuBois, B; Singh, H | 1 |
Dehé, C; Gagnadoux, F; Hureaux, J; Person, C; Priou, P; Racineux, JL; Urban, T | 1 |
Bekers, O; Drent, M; du Bois, RM; Gorgels, AP; Hansell, DM; Nicholson, AG; Singh, S; van Suylen, RJ | 1 |
3 other study(ies) available for venlafaxine hydrochloride and Pneumonia
Article | Year |
---|---|
Pharmacogenomics in the clinic: genetic polymorphism contributing to venlafaxine-associated heart failure.
Topics: Adult; Azithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Drug Interactions; Heart Failure; Humans; Male; Pharmacogenetics; Pneumonia; Polymorphism, Genetic; Venlafaxine Hydrochloride | 2019 |
[Drug-induced pneumonitis in a patient treated with venlafaxine and propanolol].
Topics: 1-Propanol; Cyclohexanols; Drug Interactions; Female; Humans; Liver Cirrhosis; Middle Aged; Pneumonia; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2008 |
Drug-induced pneumonitis and heart failure simultaneously associated with venlafaxine.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Male; Middle Aged; Pneumonia; Venlafaxine Hydrochloride; Ventricular Dysfunction, Left | 2003 |